Company Overview of Jaleva Pharmaceuticals, LLC
Jaleva Pharmaceuticals, LLC, a specialty pharmaceutical company, engages in the research and development of dermal drug delivery system that promotes transmucosal and topical delivery of medications for central nervous system markets. Its products include Mast-R-Prep, a chlorhexidine-based surgical skin prep product; and Stayzon, an antibiotic surgical adhesive. The company’s formulations are designed to provide delivery of alprazolam for anxiety; ondansetron for nausea; sumitriptan for migraines; fentanyl for pain; and nicotine as an aid to smoking cessation. Jaleva Pharmaceuticals, LLC was founded in 1999 and is based in San Diego, California.
3030 Bunker Hill Street
San Diego, CA 92109
Founded in 1999
Key Executives for Jaleva Pharmaceuticals, LLC
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Jaleva Pharmaceuticals, LLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.